Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment. [electronic resource]
Producer: 20180917Description: 1219-1227 p. digitalISSN:- 1349-7235
- Aged
- Anilides -- therapeutic use
- Antiviral Agents -- therapeutic use
- Carbamates -- therapeutic use
- Case-Control Studies
- Cyclopropanes
- Cytochrome P-450 CYP3A -- metabolism
- Drug Therapy, Combination
- Female
- Genotype
- Hepatitis C -- drug therapy
- Hepatitis C, Chronic -- drug therapy
- Humans
- Hydroxycholesterols -- blood
- Imidazoles -- therapeutic use
- Interferons -- administration & dosage
- Isoquinolines -- therapeutic use
- Lactams, Macrocyclic
- Macrocyclic Compounds -- therapeutic use
- Male
- Middle Aged
- Proline -- analogs & derivatives
- Pyrrolidines
- Ritonavir -- therapeutic use
- Sex Factors
- Sulfonamides -- therapeutic use
- Treatment Failure
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.